EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disulfiram ameliorates bone loss in ovariectomized mice by suppressing osteoclastogenesis

Tatsuyuki Fukui, Asuka Terashima, Yasunori Omata, Ryota Chijimatsu, Kazuo Okamoto, Masayuki Tsukasaki, Yukiko Fukuda, Tadayoshi Hayata, Akiyoshi Saitoh, Etsuko Toda, Hiroshi Takayanagi, Sakae Tanaka und 2 weitere

Journal of Bone and Mineral Metabolism · 2025

DOI: 10.1007/s00774-024-01555-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bone and Mineral Metabolism, 2025. Verfasst von Tatsuyuki Fukui und 13 weiteren Autor:innen. Beteiligte Einrichtung: Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. Hauptthemen laut MEDLINE: Ovariectomy, Osteoclasts, Osteogenesis, Disulfiram. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, The University of Tokyo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Disulfiram (DSF), known as an anti-alcoholism drug, has been reported to suppress osteoclast differentiation in vitro; however, it remains uncertain whether DSF is effective in preventing osteoclastogenesis in vivo. This study aimed to investigate the effect of DSF administration in osteoporotic mice and its contribution to osteoclastogenesis in vivo. Materials and methods The bone phenotype of ovariectomized mice, both treated and untreated with DSF, was examined using microcomputed tomography analysis. Osteoclastic and osteoblastic parameters were assessed through bone morphometric analysis. The direct effect of DSF on osteoblastogenesis in vitro was evaluated via a primary osteoblast culture experiment. The expression of genes related to DSF targets ( Nup85 , Ccr2 , and Ccr5 ) in osteoclast-lineage cells was examined using scRNA-seq analysis and flow cytometry analysis using the bone marrow cells from ovariectomized mice. The impact of DSF on osteoclast-lineage cells was assessed using primary cultures of osteoclasts.

Results

DSF administration ameliorated ovariectomy-induced bone loss and mitigated the increase of osteoclasts without affecting osteoblastogenesis. The scRNA-seq data revealed that osteoclast precursor cells expressed Nup85 , Ccr2 , and Ccr5 . CCR2 and CCR5-positive cells in osteoclast precursor cells within bone marrow increased following ovariectomy, and this increase was canceled by DSF administration. Finally, we found that DSF had a significant inhibitory effect on osteoclastogenesis in the early stage by suppressing Tnfrsf11a expression.

Conclusion

This study demonstrates that DSF could be a candidate for osteoporosis therapies because it suppresses osteoclastogenesis from an early stage in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OvariectomyOsteoclastsOsteogenesisDisulfiramBone ResorptionOsteoporosisAnimalsFemaleMiceCell DifferentiationMice, Inbred C57BLX-Ray Microtomography

Stichwörter der Autor:innen

DSFOsteoclast precursorOsteoclastogenesisOsteoporosisscRNA-seq analysis

Substanzen

Disulfiram

Autor:innen und Institutionen

  • Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Bone and Cartilage Regenerative Medicine, The University of Tokyo Hospital, Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. tera-ort@m.u-tokyo.ac.jp.
  • Bone and Cartilage Regenerative Medicine, The University of Tokyo Hospital, Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Center for Comprehensive Genomic Medicine, Okayama University Hospital, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
  • Department of Osteoimmunology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
  • Division of Immune Environment Dynamics, Cancer Research Institute, Kanazawa University, Kakuma-Machi, Kanazawa, 920-1192, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • The University of Tokyo

Zitieren

APA

Fukui, T., Terashima, A., Omata, Y., Chijimatsu, R., Okamoto, K., Tsukasaki, M., Fukuda, Y., Hayata, T., Saitoh, A., Toda, E., Takayanagi, H., Tanaka, S., Terashima, Y., & Saito, T. (2025). Disulfiram ameliorates bone loss in ovariectomized mice by suppressing osteoclastogenesis. Journal of Bone and Mineral Metabolism. https://doi.org/10.1007/s00774-024-01555-x

Vancouver

Fukui T, Terashima A, Omata Y, Chijimatsu R, Okamoto K, Tsukasaki M, et al. Disulfiram ameliorates bone loss in ovariectomized mice by suppressing osteoclastogenesis. Journal of Bone and Mineral Metabolism. 2025. doi:10.1007/s00774-024-01555-x

BibTeX
@article{Fukui2025,
  author = {Fukui, Tatsuyuki and Terashima, Asuka and Omata, Yasunori and Chijimatsu, Ryota and Okamoto, Kazuo and Tsukasaki, Masayuki and Fukuda, Yukiko and Hayata, Tadayoshi and Saitoh, Akiyoshi and Toda, Etsuko and Takayanagi, Hiroshi and Tanaka, Sakae and Terashima, Yuya and Saito, Taku},
  title = {Disulfiram ameliorates bone loss in ovariectomized mice by suppressing osteoclastogenesis},
  journal = {Journal of Bone and Mineral Metabolism},
  year = {2025},
  doi = {10.1007/s00774-024-01555-x}
}
Kostenlos starten →